These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32019392)

  • 1. Management of mild cognitive impairment (MCI): The need for national and international guidelines.
    Kasper S; Bancher C; Eckert A; Förstl H; Frölich L; Hort J; Korczyn AD; Kressig RW; Levin O; Palomo MSM
    World J Biol Psychiatry; 2020 Oct; 21(8):579-594. PubMed ID: 32019392
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
    CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Ong PA; Yuda T; Ng LL; Mamun K; Merchant RA; Chen C; Dominguez J; Marasigan S; Ampil E; Nguyen VT; Yusoff S; Chan YF; Yong FM; Krairit O; Suthisisang C; Senanarong V; Ji Y; Thukral R; Ihl R
    CNS Neurosci Ther; 2019 Feb; 25(2):288-298. PubMed ID: 30648358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion.
    Cummings J; Passmore P; McGuinness B; Mok V; Chen C; Engelborghs S; Woodward M; Manzano S; Garcia-Ribas G; Cappa S; Bertolucci P; Chu LW
    Alzheimers Res Ther; 2019 Aug; 11(1):73. PubMed ID: 31421681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
    Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
    Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
    Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
    Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective.
    Lautenschlager NT; Ihl R; Müller WE
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S46-50. PubMed ID: 22784429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'It's definitely not Alzheimer's': Perceived benefits and drawbacks of a mild cognitive impairment diagnosis.
    Gomersall T; Smith SK; Blewett C; Astell A
    Br J Health Psychol; 2017 Nov; 22(4):786-804. PubMed ID: 28628736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Cognitive Impairment and Mild Dementia: The Role of
    Tomino C; Ilari S; Solfrizzi V; Malafoglia V; Zilio G; Russo P; Proietti S; Marcolongo F; Scapagnini G; Muscoli C; Rossini PM
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33915701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
    Budson AE; Solomon PR
    Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
    Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study.
    Jak AJ; Preis SR; Beiser AS; Seshadri S; Wolf PA; Bondi MW; Au R
    J Int Neuropsychol Soc; 2016 Oct; 22(9):937-943. PubMed ID: 27029348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore.
    Ng A; Chew I; Narasimhalu K; Kandiah N
    Singapore Med J; 2013 Nov; 54(11):616-9. PubMed ID: 24276096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.